Pfizer's Covid Vaccine Sales To Cross Over $50 Billion This Year

Pfizer forecast more than $50 billion in 2022 sales for its COVID-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of...

from NDTV News - World-news https://ift.tt/bnSRczB